Maximising R+D efforts through better epidemiology understanding

In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, talks to Mike Hughes, Senior Director of Epidemiology at DRG. With epidemiology entering our daily vernacular, thanks to the Covid-19 pandemic, Mike gives a definition of what it is, the approaches used to model epidemiology associated with diseases and how it’s beneficial across all stages of research and development in pharma. In particular, they talk about the value epidemiology can bring to decision making and how it can aid in maximizing R&D efforts and investment decisions surrounding pipeline development and go to market plans.

Hosted on Acast. See acast.com/privacy for more information.